Management of antithrombotic agents and current issues in patients undergoing endoscopic submucosal dissection
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Park, Chan Hyuk | - |
dc.date.accessioned | 2021-07-30T04:55:15Z | - |
dc.date.available | 2021-07-30T04:55:15Z | - |
dc.date.created | 2021-05-11 | - |
dc.date.issued | 2019-07 | - |
dc.identifier.issn | 2636-0004 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/2183 | - |
dc.description.abstract | Postoperative bleeding is a common adverse event in endoscopic submucosal dissection (ESD) and may be life-threatening. Postoperative bleeding occurs frequently in patients treated with antithrombotic agents, including aspirin, antiplatelet agents, warfarin, and non-vitamin K-dependent oral anticoagulants. Due to the aging population and the increase in the risk of thromboembolic disease, the number of patients who require antithrombotic therapy has increased. To date, several clinical studies have been conducted and several global guidelines have been updated. Nevertheless, determining the optimal use of antithrombotic agents in patients undergoing ESD is still challenging, and recommendations for the use of these agents vary slightly across different guidelines. In this review, I summarized the current guidelines and discussed several ongoing issues with the management of antithrombotic agents in patients undergoing ESD. Copyright | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | SOC GASTROINTESTINAL INTERVENTION | - |
dc.title | Management of antithrombotic agents and current issues in patients undergoing endoscopic submucosal dissection | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Park, Chan Hyuk | - |
dc.identifier.doi | 10.18528/ijgii190010 | - |
dc.identifier.scopusid | 2-s2.0-85105829707 | - |
dc.identifier.wosid | 000521646200004 | - |
dc.identifier.bibliographicCitation | INTERNATIONAL JOURNAL OF GASTROINTESTINAL INTERVENTION, v.8, no.3, pp.116 - 122 | - |
dc.relation.isPartOf | INTERNATIONAL JOURNAL OF GASTROINTESTINAL INTERVENTION | - |
dc.citation.title | INTERNATIONAL JOURNAL OF GASTROINTESTINAL INTERVENTION | - |
dc.citation.volume | 8 | - |
dc.citation.number | 3 | - |
dc.citation.startPage | 116 | - |
dc.citation.endPage | 122 | - |
dc.type.rims | ART | - |
dc.type.docType | Review | - |
dc.identifier.kciid | ART002490680 | - |
dc.description.journalClass | 2 | - |
dc.description.isOpenAccess | Y | - |
dc.description.journalRegisteredClass | kci | - |
dc.description.journalRegisteredClass | other | - |
dc.relation.journalResearchArea | Gastroenterology & Hepatology | - |
dc.relation.journalWebOfScienceCategory | Gastroenterology & Hepatology | - |
dc.subject.keywordPlus | S-WARFARIN METABOLISM | - |
dc.subject.keywordPlus | EARLY GASTRIC-CANCER | - |
dc.subject.keywordPlus | LOW-DOSE ASPIRIN | - |
dc.subject.keywordPlus | BLEEDING RISK | - |
dc.subject.keywordPlus | POPULATION DIFFERENCES | - |
dc.subject.keywordPlus | EUROPEAN-SOCIETY | - |
dc.subject.keywordPlus | ANTIPLATELET | - |
dc.subject.keywordPlus | INCREASE | - |
dc.subject.keywordPlus | JAPANESE | - |
dc.subject.keywordPlus | OUTCOMES | - |
dc.subject.keywordAuthor | Anticoagulants | - |
dc.subject.keywordAuthor | Antiplatelet agent | - |
dc.subject.keywordAuthor | Antithrombotic agent | - |
dc.subject.keywordAuthor | Aspirin | - |
dc.subject.keywordAuthor | Endoscopic mucosal resection | - |
dc.identifier.url | https://www.ijgii.org/journal/view.html?doi=10.18528/ijgii190010 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1365
COPYRIGHT © 2021 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.